Yog vim li cas Inozyme Pharma (INZY) Shares Yog Trading siab dua hnub no

  • Inozyme Pharma Inc (Nasdaq: INZY) tshaj tawm topline pharmacokinetic (PK), pharmacodynamic (PD), thiab cov ntaub ntawv kev nyab xeeb los ntawm qhov kev sim Theem 1/2 txuas ntxiv ntawm INZ-701 hauv ENPP1 Deficiency thiab ABCC6 Deficiency (PXE).

  • Kev nrawm, qhov tseem ceeb, thiab kev nce ntxiv hauv cov ntshav plasma pyrophosphate (PPi) tau pom, thiab cov ntaub ntawv txhawb nqa cov neeg mob tau tshaj tawm cov txiaj ntsig hauv txhua qhov koob tshuaj hauv ENPP1 Kev sim tsis txaus.

  • Kuj nyeem: Inozyme Pharma Post txhawb nqa cov ntaub ntawv thaum ntxov los ntawm kev sim tshuaj caj ces.

  • PPi ua lub luag haujlwm tseem ceeb hauv inhibiting dystrophic calcification.

  • Kev nce nrawm thiab tseem ceeb hauv PPi tau pom nyob rau hauv tag nrho cov koob tshuaj, nrog rau kev nce ntxiv tau pom nyob rau hauv cov koob tshuaj ntau tshaj plaws hauv kev sim PXE.

  • INZ-701 feem ntau tau txais txiaj ntsig zoo thiab nthuav tawm qhov kev nyab xeeb zoo hauv ob qho kev sim.

  • Inozyme Pharma cia siab tias yuav tshaj tawm cov nyiaj ntsuab, cov nyiaj sib npaug, thiab kev nqis peev luv luv ntawm kwv yees li $ 127.9 lab raws li lub Kaum Ob Hlis 31, 2022.

  • Lub tuam txhab cia siab tias nws cov nyiaj tshuav nyiaj li cas, suav nrog ntxiv $ 20 lab qiv nyiaj rau Lub Ob Hlis 15, 2023, nyob rau hauv nws cov nuj nqis uas twb muaj lawm, yuav ua rau nws muaj peev xwm nyiaj tau los rau hauv lub quarter thib plaub ntawm 2024, uas sawv cev rau qhov nce ntawm ob peb lub hlis twg. kev taw qhia yav dhau los.

  • nqe Action: INZY shares tau nce 26.6% ntawm $ 2.81 thaum lub sijhawm ua ntej kev lag luam ntawm daim tshev kawg hnub Thursday.

Tsis txhob nco lub sijhawm ceeb toom ntawm koj cov khoom lag luam - koom Lub Npe Lub Npe Pro dawb! Sim cov cuab yeej uas yuav pab koj nqis peev smarter, sai dua, thiab zoo dua.

Tshooj no Yog vim li cas Inozyme Pharma (INZY) Shares Yog Trading siab dua hnub no Ameslikas nyob rau hauv benzinga.com

.

© 2023 Benzinga.com. Benzinga tsis muab lus qhia txog peev. Qoob loo.

Tau qhov twg los: https://finance.yahoo.com/news/why-inozyme-pharma-inzy-shares-135922306.html